Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells

被引:92
作者
Takakura, M
Kyo, S
Inoue, M
Wright, WE
Shay, JW
机构
[1] Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA
[2] Kanazawa Univ, Sch Med, Dept Obstet & Gynecol, Kanazawa, Ishikawa 9208641, Japan
关键词
D O I
10.1128/MCB.25.18.8037-8043.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptional regulation of the human telomerase catalytic subunit (hTERT) plays a critical role in telomerase activity. Approximately 200 by of the proximal core promoter is responsible for basic hTERT expression; however, the function of the distal regulatory elements remains unclear. The transcription factor activator protein 1 (AP-1) is involved in cellular proliferation, differentiation, carcinogenesis, and apoptosis and is expressed broadly in both cancer and normal cells. There are several putative AP-1 sites in the hTERT promoter, but their functions are unknown. The present study examined the regulatory role of AP-1 in hTERT gene transcription. Overexpression of AP-1 leads to transcriptional suppression of hTERT in cancer cells. The combination of c-Fos and c-Jun or c-Fos and JunD strongly suppresses hTERT promoter activity in transient-expression analyses. The hTERT promoter region between -2000 and -378 is responsible for this function. Gel shift and supershift analyses, as well as ChIP, show binding of JunD and c-Jun on two putative AP-1 sites within this region. Mutations in the AP-1 binding sites rescued suppressions caused by AP-1, suggesting this is a direct regulation of the hTERT promoter. In contrast, there was no effect on mTERT expression or mTERT promoter activity by AP-1 overexpression in mouse fibroblasts. The species-specific function of AP-1 in TERT expression may in part help explain the difference in telomerase activity between normal human and mouse cells.
引用
收藏
页码:8037 / 8043
页数:7
相关论文
共 47 条
[1]   c-Jun-NH2 kinase (JNK) contributes to the regulation of c-Myc protein stability [J].
Alarcon-Vargas, D ;
Ronai, Z .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (06) :5008-5016
[2]  
Alfonso-De Matte MY, 2002, CANCER RES, V62, P4575
[3]   A role for AP-1 in apoptosis: the case for and against [J].
Ameyar, M ;
Wisniewska, M ;
Weitzman, JB .
BIOCHIMIE, 2003, 85 (08) :747-752
[4]   ACTIVATION OF CAMP AND MITOGEN RESPONSIVE GENES RELIES ON A COMMON NUCLEAR FACTOR [J].
ARIAS, J ;
ALBERTS, AS ;
BRINDLE, P ;
CLARET, FX ;
SMEAL, T ;
KARIN, M ;
FERAMISCO, J ;
MONTMINY, M .
NATURE, 1994, 370 (6486) :226-229
[5]   Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA [J].
Autexier, C ;
Pruzan, R ;
Funk, WD ;
Greider, CW .
EMBO JOURNAL, 1996, 15 (21) :5928-5935
[6]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[7]  
BUSHEL P, 1995, ONCOGENE, V10, P1361
[8]   The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter [J].
Cong, YS ;
Wen, JP ;
Bacchetti, S .
HUMAN MOLECULAR GENETICS, 1999, 8 (01) :137-142
[9]   TELOMERASE ACTIVITY IN NORMAL LEUKOCYTES AND IN HEMATOLOGIC MALIGNANCIES [J].
COUNTER, CM ;
GUPTA, J ;
HARLEY, CB ;
LEBER, B ;
BACCHETTI, S .
BLOOD, 1995, 85 (09) :2315-2320
[10]  
Devereux TR, 1999, CANCER RES, V59, P6087